Medication info
Posidapa Tablet 10 mg (Dapagliflozin Propanediol Hydrate)

Posidapa Tablet 10 mg (Dapagliflozin Propanediol Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›12.3mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Yellow, bi-convex, diamond-shaped film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202204699 · Approved 2022.12.29 · Insurance code 694003970

Summary

Main use
Improves type 2 diabetes, prevents worsening of chronic heart failure, and prevents worsening of chronic kidney disease
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug treatment who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
Under 18 years of age: The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improves type 2 diabetes, prevents worsening of chronic heart failure, and prevents worsening of chronic kidney disease

  • Type 2 diabetes
  • abnormal blood sugar control
  • cardiovascular diseases
  • chronic heart failure
  • heart failure
  • chronic kidney disease
  • reduced glomerular filtration rate
  • end-stage kidney disease
View approved original text

This medicine is used in conjunction with dietary and exercise therapy to assist blood sugar control in patients with type 2 diabetes. It can enhance blood sugar control effects, either as monotherapy or in combination with other medications. Additionally, it helps reduce the risk of cardiovascular events in patients with type 2 diabetes who have cardiovascular diseases or risk factors. For patients with chronic heart failure, it is used in combination with other treatments to lower the risk of death and hospitalization due to heart failure. In patients with chronic kidney disease, it is used to slow the decline of kidney function and reduce the risk of cardiovascular and kidney-related mortality. Therefore, this medicine is effectively used in improving major health issues such as diabetes, heart failure, and kidney disease.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no previous experience of antidiabetic drug treatment who are receiving this medicine in combination with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Chronic heart failure and chronic kidney disease The recommended dose of this medicine is 10 mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - eGFR less than 25 mL/min/1.73m2: Initiation of this medicine is not recommended in patients with chronic heart failure and chronic kidney disease. - Patients on dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be taken orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

Under 18 years of age: The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medicine should not be used in patients who have had allergic reactions to the active ingredient or excipients. It should also not be administered to patients with type 1 diabetes or diabetic ketoacidosis, and to those undergoing dialysis. This medicine contains lactose hydrate, hence it should not be administered to patients with lactose intolerance or specific genetic disorders. Care should be taken when using this medicine in patients with reduced fluid volume or kidney dysfunction, and blood pressure, fluid status, and kidney function should be carefully monitored before and after administration. The blood sugar control effect of this medicine may vary based on kidney function, so it is not recommended for patients with severe kidney impairment. While using this medicine, side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis may occur, so symptoms should be closely monitored. Genital infections are particularly more common in women, and if there is a history of infections, the risk of recurrence may be higher, so caution is advised. There is a risk of hypoglycemia, so dosages of insulin or sulfonylureas may need to be adjusted if taken together. This medicine may cause a reduction in fluid volume, leading to hypotension or dehydration, so elderly patients or those taking diuretics should be particularly careful. In severe cases, rare complications such as perineal necrosis may occur, so if symptoms like pain, swelling, or redness appear in the genital area or perineum, medical assistance should be sought immediately. Pregnant or breastfeeding women are advised not to use this medicine, and it should be discontinued if pregnancy is confirmed. The safety and efficacy of this medicine for children has not been established, hence it should not be used in pediatric populations. There is no specific antidote in case of overdose, so appropriate treatment should be conducted according to symptoms, and hospitalization may be required for monitoring and treatment. Generally, it is safe to drive or operate machinery while taking this medicine, but caution should be exercised for hypoglycemic symptoms if used with insulin or sulfonylureas. Lastly, it is important to keep this medicine in its original container and store it out of reach of children.

Side effects

vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, lower back pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance early in treatment, dyslipidemia, elevated serum creatinine early in treatment, increased serum urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, kidney dysfunction, rash, angioedema, weakness, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, acute pyelonephritis, chest pain, chronic gastritis, diverticulitis, intragastric air retention, frequent bowel movements, gastroenteritis, colon polyps, intestinal perforation, epigastric discomfort, functional dyspepsia, erosive gastritis, gum disorders, gum pain, hemorrhoids, hiatal hernia, irritable bowel syndrome, melena, chronic pancreatitis, urgency, diabetic nephropathy, overactive bladder, microalbuminuria, stress urinary incontinence, urinary hesitancy, urinary stones, abnormal urination, increased serum lactate, lymphocytopenia, vitamin D deficiency, increased appetite, taste disturbance, drowsiness, tension headache, carpal tunnel syndrome, cerebral infarction, diabetic neuropathy, coma, nerve compression, neuralgia, peripheral neuropathy, sleep disorders, syncope, tremor, bronchitis, shingles, sinusitis, tonsillitis, diverticulitis, herpes simplex, stye, joint abscess, laryngitis, otitis media, pelvic inflammatory disease, periapical periodontitis, pneumonia, pulmonary tuberculosis, rhinitis, toenail fungus, herpes simplex, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like syndrome, chest pain, fatigue, pain, edema, foreign body sensation, breast mass, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine bleeding, vaginal bleeding, vulvar discomfort, irregular menstruation, hair loss, dermatitis, dry skin, allergic dermatitis, contact dermatitis, diabetic foot ulcers, excessive sweating eczema, coin dermatitis, eczema, hyperkeratosis, fingertip pigmentation, skin lesions, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament strain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

Yellow, bi-convex, diamond-shaped film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.